Showing 1,321 - 1,340 results of 119,660 for search '(( 5 ((mean decrease) OR (a decrease)) ) OR ( a ((non decrease) OR (fold decrease)) ))', query time: 1.44s Refine Results
  1. 1321
  2. 1322
  3. 1323
  4. 1324

    Knockdown of VGLUT1 results in a concomitant decrease in synaptic expression of synapsin and synaptophysin. by Corbett T. Berry (296520)

    Published 2013
    “…(<b>E</b>) Synaptophysin was not decreased in KD neurons co-expressing VGLUT1 (<i>V1</i>, VGLUT1 expressing neurons; p = 0.940; n = 244 and 96 puncta from 13 and 9 axons for SCR and V1, respectively, from a representative experiment. …”
  5. 1325

    Deterioration of the anammox process at decreasing temperatures and long SRTs by Maaike Hoekstra (3915545)

    Published 2017
    “…The long SRT leads to an increase of non-active and non-anammox cells in the reactor, thereby decreasing the biomass-specific activity.…”
  6. 1326
  7. 1327
  8. 1328
  9. 1329

    ANG II treatment leads to decreased contractile function. by Renita E. Horton (847891)

    Published 2016
    “…(E) Representative stress traces generated from x-projections of films (F) ANG II treatment leads to a decrease in contractile stress generation. Control n = 85 tissues, 5 nM n = 15 tissues, 100 nM n = 69 tissues, 3 harvests. …”
  10. 1330
  11. 1331
  12. 1332

    EGCG decreases RSK2-mediated cell viability. by Hanyong Chen (320863)

    Published 2015
    “…Differences were evaluated using the Student’s t-test and the asterisk (*) indicates a significant decrease in viability in RSK2<sup>+/+</sup> MEFs compared to RSK2<sup>-/-</sup> MEFs (<i>p</i> < 0.05).…”
  13. 1333
  14. 1334
  15. 1335
  16. 1336

    Data_Sheet_1_Thrombotic Events in COVID-19 Are Associated With a Lower Use of Prophylactic Anticoagulation Before Hospitalization and Followed by Decreases in Platelet Reactivity.d... by Chantal C. Clark (10684632)

    Published 2021
    “…</p><p>Conclusion: We observed an association between the use of preexisting thromboprophylaxis and a decreased risk of TE during COVID-19. This suggests that these therapies are beneficial for coping with COVID-19 associated hypercoagulability. …”
  17. 1337
  18. 1338

    Retinoschisin secretion into the conditioned medium is decreased by addition of taxol. by Eiko Kitamura (349087)

    Published 2013
    “…Retinoschisin secretion into the medium decreases in a dose-dependent manner between 0.5 µM and 10 µM taxol. …”
  19. 1339
  20. 1340